{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:49:39Z","timestamp":1790858979706,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00228-023-03545-w","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:02:01Z","timestamp":1691136121000},"page":"1357-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"79","author":[{"given":"Lifei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongquan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"3545_CR1","doi-asserted-by":"publisher","unstructured":"Amaral DG, Anderson MP, Ansorge O et al (2018) Autism BrainNet: a network of postmortem brain banks established to facilitate autism research. Handb Clin Neurol.15031\u20139. https:\/\/doi.org\/10.1016\/b978-0-444-63639-3.00003-7.","DOI":"10.1016\/b978-0-444-63639-3.00003-7"},{"key":"3545_CR2","doi-asserted-by":"publisher","unstructured":"Maenner MJ, Shaw KA, Baio J et al (2020) Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2016. MMWR Surveill Summ 69(4):1\u201312. https:\/\/doi.org\/10.15585\/mmwr.ss6904a1.","DOI":"10.15585\/mmwr.ss6904a1"},{"key":"3545_CR3","doi-asserted-by":"publisher","unstructured":"Maenner MJ, Shaw KA, Bakian AV et al (2021) Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR Surveill Summ 70(11):1\u201316. https:\/\/doi.org\/10.15585\/mmwr.ss7011a1.","DOI":"10.15585\/mmwr.ss7011a1"},{"issue":"10321","key":"3545_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0140-6736(21)01541-5","volume":"399","author":"C Lord","year":"2022","unstructured":"Lord C, Charman T, Havdahl A et al (2022) The Lancet Commission on the future of care and clinical research in autism. Lancet 399(10321):271\u2013334. https:\/\/doi.org\/10.1016\/s0140-6736(21)01541-5","journal-title":"Lancet"},{"issue":"2","key":"3545_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/jama.2022.23661","volume":"329","author":"T Hirota","year":"2023","unstructured":"Hirota T, King BH (2023) Autism spectrum disorder: a review Jama 329(2):157\u2013168. https:\/\/doi.org\/10.1001\/jama.2022.23661","journal-title":"Autism spectrum disorder: a review Jama"},{"issue":"9","key":"3545_CR6","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/s10803-019-04120-y","volume":"50","author":"P Herscu","year":"2020","unstructured":"Herscu P, Handen BL, Arnold LE et al (2020) The SOFIA study: negative multi-center study of low dose fluoxetine on repetitive behaviors in children and adolescents with autistic disorder. J Autism Dev Disord 50(9):3233\u20133244. https:\/\/doi.org\/10.1007\/s10803-019-04120-y","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"3545_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13229-022-00488-4","volume":"13","author":"S Siafis","year":"2022","unstructured":"Siafis S, \u00c7\u0131ray O, Wu H et al (2022) Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism 13(1):10. https:\/\/doi.org\/10.1186\/s13229-022-00488-4","journal-title":"Mol Autism"},{"key":"3545_CR8","doi-asserted-by":"publisher","unstructured":"Pe\u00f1agarikano O, L\u00e1zaro MT, Lu XH et al (2015) Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med.7(271):271ra8. https:\/\/doi.org\/10.1126\/scitranslmed.3010257.","DOI":"10.1126\/scitranslmed.3010257"},{"key":"3545_CR9","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhao S, Liu X, Zheng Y, Li L, Meng S (2018) Oxytocin improves animal behaviors and ameliorates oxidative stress and inflammation in autistic mice. Biomed Pharmacother 107262\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.148.","DOI":"10.1016\/j.biopha.2018.07.148"},{"key":"3545_CR10","doi-asserted-by":"publisher","unstructured":"Lefter R, Ciobica A, Antioch I, Ababei DC, Hritcu L, Luca AC (2020) Oxytocin differentiated effects according to the administration route in a prenatal valproic acid-induced rat model of autism. Medicina (Kaunas) 56(6). https:\/\/doi.org\/10.3390\/medicina56060267.","DOI":"10.3390\/medicina56060267"},{"issue":"7042","key":"3545_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nature03701","volume":"435","author":"M Kosfeld","year":"2005","unstructured":"Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005) Oxytocin increases trust in humans. Nature 435(7042):673\u2013676. https:\/\/doi.org\/10.1038\/nature03701","journal-title":"Nature"},{"issue":"6","key":"3545_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","volume":"61","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC (2007) Oxytocin improves \u201cmind-reading\u201d in humans. Biol Psychiatry 61(6):731\u2013733. https:\/\/doi.org\/10.1016\/j.biopsych.2006.07.015","journal-title":"Biol Psychiatry"},{"issue":"5984","key":"3545_CR13","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1126\/science.1189047","volume":"328","author":"CK De Dreu","year":"2010","unstructured":"De Dreu CK, Greer LL, Handgraaf MJ et al (2010) The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 328(5984):1408\u20131411. https:\/\/doi.org\/10.1126\/science.1189047","journal-title":"Science"},{"issue":"2","key":"3545_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/jamapsychiatry.2013.3181","volume":"71","author":"T Watanabe","year":"2014","unstructured":"Watanabe T, Abe O, Kuwabara H et al (2014) Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial. JAMA Psychiat 71(2):166\u2013175. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.3181","journal-title":"JAMA Psychiat"},{"key":"3545_CR15","doi-asserted-by":"publisher","unstructured":"Kanat M, Spenthof I, Riedel A, van Elst LT, Heinrichs M, Domes G (2017) Restoring effects of oxytocin on the attentional preference for faces in autism. Transl Psychiatry 7(4):e1097. https:\/\/doi.org\/10.1038\/tp.2017.67.","DOI":"10.1038\/tp.2017.67"},{"key":"3545_CR16","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions: John Wiley & Sons","DOI":"10.1002\/9781119536604"},{"issue":"7454","key":"3545_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"Group GW","year":"2004","unstructured":"Group GW (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490","journal-title":"BMJ"},{"issue":"3","key":"3545_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/xeb.0000000000000065","volume":"13","author":"C Tufanaru","year":"2015","unstructured":"Tufanaru C, Munn Z, Stephenson M, Aromataris E (2015) Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 13(3):196\u2013207. https:\/\/doi.org\/10.1097\/xeb.0000000000000065","journal-title":"Int J Evid Based Healthc"},{"issue":"9","key":"3545_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2015.162","volume":"21","author":"CJ Yatawara","year":"2016","unstructured":"Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ (2016) The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry 21(9):1225\u20131231. https:\/\/doi.org\/10.1038\/mp.2015.162","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3545_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41380-022-01845-8","volume":"28","author":"AJ Guastella","year":"2023","unstructured":"Guastella AJ, Boulton KA, Whitehouse AJO et al (2023) The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial. Mol Psychiatry 28(2):834\u2013842. https:\/\/doi.org\/10.1038\/s41380-022-01845-8","journal-title":"Mol Psychiatry"},{"issue":"16","key":"3545_CR21","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","volume":"385","author":"L Sikich","year":"2021","unstructured":"Sikich L, Kolevzon A, King BH et al (2021) Intranasal oxytocin in children and adolescents with autism spectrum disorder. N Engl J Med 385(16):1462\u20131473. https:\/\/doi.org\/10.1056\/NEJMoa2103583","journal-title":"N Engl J Med"},{"issue":"4","key":"3545_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/jcpp.12305","volume":"56","author":"AJ Guastella","year":"2015","unstructured":"Guastella AJ, Gray KM, Rinehart NJ et al (2015) The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiatry 56(4):444\u2013452. https:\/\/doi.org\/10.1111\/jcpp.12305","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"3545_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000524543","volume":"91","author":"J Le","year":"2022","unstructured":"Le J, Zhang L, Zhao W et al (2022) Infrequent intranasal oxytocin followed by positive social interaction improves symptoms in autistic children: a pilot randomized clinical trial. Psychother Psychosom 91(5):335\u2013347. https:\/\/doi.org\/10.1159\/000524543","journal-title":"Psychother Psychosom"},{"key":"3545_CR24","doi-asserted-by":"publisher","unstructured":"Huang Y, Huang X, Ebstein RP, Yu R (2021) Intranasal oxytocin in the treatment of autism spectrum disorders: a multilevel meta-analysis. Neurosci Biobehav Rev 12218\u201327. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.12.028.","DOI":"10.1016\/j.neubiorev.2020.12.028"},{"key":"3545_CR25","doi-asserted-by":"publisher","unstructured":"Zhao F, Zhang H, Wang P et al (2022) Oxytocin and serotonin in the modulation of neural function: neurobiological underpinnings of autism-related behavior. Front Neurosci 16919890. https:\/\/doi.org\/10.3389\/fnins.2022.919890.","DOI":"10.3389\/fnins.2022.919890"},{"key":"3545_CR26","doi-asserted-by":"publisher","unstructured":"Kepser LJ, Homberg JR (2015) The neurodevelopmental effects of serotonin: a behavioural perspective. Behav Brain Res 2773\u20132813. https:\/\/doi.org\/10.1016\/j.bbr.2014.05.022.","DOI":"10.1016\/j.bbr.2014.05.022"},{"key":"3545_CR27","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Sanchis S (2014) Neurobiological foundations of multisensory integration in people with autism spectrum disorders: the role of the medial prefrontal cortex. Front Hum Neurosci 8970. https:\/\/doi.org\/10.3389\/fnhum.2014.00970.","DOI":"10.3389\/fnhum.2014.00970"},{"key":"3545_CR28","doi-asserted-by":"publisher","unstructured":"Andari E, Richard N, Leboyer M, Sirigu A (2016) Adaptive coding of the value of social cues with oxytocin, an fMRI study in autism spectrum disorder. Cortex 7679\u201388. https:\/\/doi.org\/10.1016\/j.cortex.2015.12.010.","DOI":"10.1016\/j.cortex.2015.12.010"},{"key":"3545_CR29","doi-asserted-by":"publisher","unstructured":"Gordon I, Jack A, Pretzsch CM et al (2016) Intranasal oxytocin enhances connectivity in the neural circuitry supporting social motivation and social perception in children with autism. Sci Rep 635054. https:\/\/doi.org\/10.1038\/srep35054.","DOI":"10.1038\/srep35054"},{"issue":"3","key":"3545_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/pcn.12627","volume":"72","author":"Q Cai","year":"2018","unstructured":"Cai Q, Feng L, Yap KZ (2018) Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder. Psychiatry Clin Neurosci 72(3):140\u2013151. https:\/\/doi.org\/10.1111\/pcn.12627","journal-title":"Psychiatry Clin Neurosci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03545-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T03:21:58Z","timestamp":1694748118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03545-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}